Literature DB >> 12533184

Visibility of neurofibromatosis 1 and psychiatric morbidity.

Pierre Wolkenstein, Jacques Zeller, Jean Revuz, Emmanuel Ecosse, Alain Leplège.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12533184     DOI： 10.1001/archderm.139.1.103

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  7 in total

1.  Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.

Authors:  J S Cohen; H P Levy; J Sloan; J Dariotis; B B Biesecker
Journal:  Clin Genet       Date:  2015-01-20       Impact factor: 4.438

2.  The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.

Authors:  Samira Foji; Eesa Mohammadi; Akram Sanagoo; Leila Jouybari
Journal:  Iran J Nurs Midwifery Res       Date:  2021-07-20

3.  Quality of Life in Adults with Neurofibromatosis 1 in Brazil.

Authors:  Natália Parenti Bicudo; Balduíno Ferreira de Menezes Neto; Lucimar Retto da Silva de Avó; Carla Maria Ramos Germano; Débora Gusmão Melo
Journal:  J Genet Couns       Date:  2016-03-05       Impact factor: 2.537

4.  Brace and deformity-related stress level in females with adolescent idiopathic scoliosis based on the Bad Sobernheim Stress Questionnaires.

Authors:  Ewa Misterska; Maciej Glowacki; Jerzy Harasymczuk
Journal:  Med Sci Monit       Date:  2011-02

5.  Neurofibromatosis type 1 and the "elephant man's" disease: the confusion persists: an ethnographic study.

Authors:  Claire-Marie Legendre; Catherine Charpentier-Côté; Régen Drouin; Chantal Bouffard
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

6.  A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1.

Authors:  G Hamoy-Jimenez; H A Elahmar; M Mendoza; R H Kim; V Bril; C Barnett
Journal:  Orphanet J Rare Dis       Date:  2022-02-08       Impact factor: 4.123

7.  Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.

Authors:  Daphne L Wang; Kelly B Smith; Sonia Esparza; Fawn A Leigh; Alona Muzikansky; Elyse R Park; Scott R Plotkin
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.